EI
FENC icon

EAM Investors’s Fennec Pharmaceuticals FENC Stock Holding History

EAM Investors’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-78,661
Closed -$653K – 290
2025
Q2 		$653K Buy
+78,661
New +$538K 0.1% 192
2024
Q1 		– Sell
-65,795
Closed -$738K – 276
2023
Q4 		$738K Buy
+65,795
New +$545K 0.13% 188
2023
Q1 		– Sell
-176,452
Closed -$1.69M – 295
2022
Q4 		$1.69M Sell
176,452
-368
-0.2% -$3.26K 0.35% 121
2022
Q3 		$1.43M Buy
+176,820
New +$1.21M 0.31% 139

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM Investors's FENC Position: Q3 2025 in Review

EAM Investors sold out of Fennec Pharmaceuticals (FENC) in Q3 2025, closing a stake of 78,661 shares — an estimated $653K sold.

EAM Investors first reported a position in FENC in Q3 2022 and held it in 4 quarters. The position peaked at $1.69M in Q4 2022. 84 funds tracked by Wall St. Rank hold FENC as of Q3 2025.

  • EAM Investors reported no remaining Fennec Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • EAM Investors sold 78,661 Fennec Pharmaceuticals shares in Q3 2025, an estimated $653K.
  • EAM Investors first reported a position in Fennec Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • EAM Investors's Fennec Pharmaceuticals position peaked at $1.69M in Q4 2022.
  • 84 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2025.

Based on EAM Investors's 13F filing for Q3 2025, filed 14 Nov 2025.